{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:50:01Z","timestamp":1787003401291,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite the high prevalence of osteoporosis in liver cirrhosis, the indication of bisphosphonates for patients with esophageal varices has been avoided due to risk of digestive mucosal damage. Therefore, this study aimed to evaluate the safety profile of risedronate treatment for patients with osteoporosis, liver cirrhosis and esophageal varices with low risk of bleeding. A total of 120 patients were allocated into two groups according to their bone mineral density measured by dual-energy X-ray absorptiometry. In the intervention group, 57 subjects with osteoporosis received oral risedronate at 35\u2009mg weekly plus daily calcium and vitamin D supplementation. In the control group, 63 subjects with osteopenia received only calcium and vitamin D. The groups received the treatment for one year and underwent surveillance endoscopies at six and 12 months, as well as a control dual-energy X-ray absorptiometry after a 12-month follow-up. The study received Institutional Review Board approval. The groups had not only comparable Model for End-stage Liver Disease score and esophageal varices degree, but also similar incidence of digestive adverse effects. A significant improvement was achieved in the intervention group in the lumbar spine T score (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). The results suggest that risedronate may be safely used in liver cirrhosis and esophageal varices with low bleeding risk under endoscopic surveillance, thus allowing bone mass recovery.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-55603-y","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T10:11:38Z","timestamp":1576145498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-7541","authenticated-orcid":false,"given":"Talles Bazeia","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Alves Amaral","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio Rubens de Carvalho","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Faria","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Antonio","family":"Caramori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-6739","authenticated-orcid":false,"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-6895","authenticated-orcid":false,"given":"Fernando Gomes","family":"Romeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"55603_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0884533612470145","volume":"28","author":"A Yadav","year":"2013","unstructured":"Yadav, A. & Carey, E. J. Osteoporosis in chronic liver disease. Nutr. Clin. Pr. 28, 52\u201364 (2013).","journal-title":"Nutr. Clin. Pr."},{"key":"55603_CR2","unstructured":"U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General (US), http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK45513 (2004)."},{"key":"55603_CR3","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","volume":"20","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen, B., van Staa, T., Ariely, R., Olson, M. & Cooper, C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos. Int. 20, 1633\u20131650 (2009).","journal-title":"Osteoporos. Int."},{"key":"55603_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/hep.510280315","volume":"28","author":"FJ Gallego-Rojo","year":"1998","unstructured":"Gallego-Rojo, F. J. et al. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology. 28, 695\u2013699 (1998).","journal-title":"Hepatology."},{"key":"55603_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S8756-3282(01)00420-3","volume":"28","author":"M Komine","year":"2001","unstructured":"Komine, M. et al. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone. 28, 474\u2013483 (2001).","journal-title":"Bone."},{"key":"55603_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","volume":"140","author":"P Angulo","year":"2011","unstructured":"Angulo, P. et al. Bone disease in patients with primary sclerosing cholangitis. Gastroenterology. 140, 180\u2013188 (2011).","journal-title":"Gastroenterology."},{"key":"55603_CR7","first-page":"82","volume":"31","author":"V Goel","year":"2010","unstructured":"Goel, V. & Kar, P. Hepatic osteodystrophy. Trop. Gastroenterol. 31, 82\u201386 (2010).","journal-title":"Trop. Gastroenterol."},{"key":"55603_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0741-8329(95)02006-3","volume":"12","author":"A Mart\u00ednez-Riera","year":"1995","unstructured":"Mart\u00ednez-Riera, A. et al. Alcoholic hypogonadism: hormonal response to clomiphene. Alcohol. 12, 581\u2013587 (1995).","journal-title":"Alcohol."},{"key":"55603_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF03346365","volume":"31","author":"C Santori","year":"2008","unstructured":"Santori, C. et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J. Endocrinol. Invest. 31, 321\u2013326 (2008).","journal-title":"J. Endocrinol. Invest."},{"key":"55603_CR10","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","volume":"50","author":"JD Collier","year":"2002","unstructured":"Collier, J. D., Ninkovic, M. & Compston, J. E. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut. 50, i1\u2013i9 (2002).","journal-title":"Gut."},{"key":"55603_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","volume":"125","author":"WD Leslie","year":"2003","unstructured":"Leslie, W. D., Bernstein, C. N. & Leboff, M. S. American Gastroenterological Association Clinical Practice Committee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology. 125, 941\u2013966 (2003).","journal-title":"Gastroenterology."},{"key":"55603_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jebm.12286","volume":"11","author":"K Wijarnpreecha","year":"2018","unstructured":"Wijarnpreecha, K., Thongprayoon, C., Panjawatanan, P. & Ungprasert, P. Hepatitis C virus infection and risk of osteoporotic fracture: a systematic review and meta-analysis. J. Evid. Based Med. 11, 20\u201325 (2018).","journal-title":"J. Evid. Based Med."},{"key":"55603_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1423462","volume":"2016","author":"LA Santos","year":"2015","unstructured":"Santos, L. A. & Romeiro, F. G. Diagnosis and management of cirrhosis-related osteoporosis. Biomed. Res. Int. 2016, 1\u201312 (2015).","journal-title":"Biomed. Res. Int."},{"key":"55603_CR14","first-page":"185","volume":"11","author":"A Gatta","year":"2014","unstructured":"Gatta, A., Verardo, A., Di Pascoli, M., Giannini, S. & Bolognesi, M. Hepatic osteodystrophy. Clin. Cases Miner. Bone Metab. 11, 185\u2013191 (2014).","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"55603_CR15","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles, K. W. et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N. Engl. J. Med. 357, 1799\u20131809 (2007).","journal-title":"N. Engl. J. Med."},{"key":"55603_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00198-010-1411-2","volume":"22","author":"LA Beaupre","year":"2011","unstructured":"Beaupre, L. A. et al. Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos. Int. 22, 983\u2013991 (2011).","journal-title":"Osteoporos. Int."},{"key":"55603_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho, P. M. et al. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr. Pr. 22, 1\u201342 (2016).","journal-title":"Endocr. Pr."},{"key":"55603_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0895-4356(01)00461-9","volume":"55","author":"S Hern\u00e1ndez-D\u00edaz","year":"2002","unstructured":"Hern\u00e1ndez-D\u00edaz, S. & Rodr\u00edguez, L. Incidence of serious upper gastrointestinal bleeding\/perforation in the general population: review of epidemiologic studies. J. Clin. Epidemiol. 55, 157\u2013163 (2002).","journal-title":"J. Clin. Epidemiol."},{"key":"55603_CR19","unstructured":"Compston, J. & Shane, E. Bone disease of organ transplantation (eds Compston, J. & Shane, E.) 426 (Elsevier, 2005)."},{"key":"55603_CR20","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/MEG.0b013e32834cd6f6","volume":"23","author":"A Yurci","year":"2011","unstructured":"Yurci, A. et al. Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease. Eur. J. Gastroenterol. Hepatol. 23, 1206\u20131212 (2011).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"55603_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2050640615584535","volume":"4","author":"R Bansal","year":"2016","unstructured":"Bansal, R., Kumar, M., Sachdeva, P. & Kumar, A. Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation. United Eur. Gastroenterol. J. 4, 77\u201383 (2016).","journal-title":"United Eur. Gastroenterol. J."},{"key":"55603_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C. & Khaltaev, N. The diagnosis of osteoporosis. J. Bone Miner. Res. 9, 1137\u20131141 (1994).","journal-title":"J. Bone Miner. Res."},{"key":"55603_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1053\/gast.2000.16517","volume":"119","author":"FL Lanza","year":"2000","unstructured":"Lanza, F. L., Hunt, R. H., Thomson, A. B., Provenza, J. M. & Blank, M. A. Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology. 119, 631\u2013638 (2000).","journal-title":"Gastroenterology."},{"key":"55603_CR24","first-page":"144","volume":"7","author":"O Bock","year":"2007","unstructured":"Bock, O. et al. Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. J. Musculoskelet Neuronal Interact. 7, 144\u2013148 (2007).","journal-title":"J. Musculoskelet Neuronal Interact."},{"key":"55603_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0300-5089(21)00034-1","volume":"2","author":"T Sakita","year":"1973","unstructured":"Sakita, T. Endoscopy in diagnosis of early gastric cancer. Clin. Gastroenterol. 2, 345\u2013360 (1973).","journal-title":"Clin. Gastroenterol."},{"key":"55603_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"LR Lundell","year":"1999","unstructured":"Lundell, L. R. et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 45, 172\u2013180 (1999).","journal-title":"Gut."},{"key":"55603_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/BF02468653","volume":"10","author":"K Inokuchi","year":"1980","unstructured":"Inokuchi, K. The general rules for recording endoscopic findings on esophageal varices. Jpn. J. Surg. 10, 84\u201387 (1980).","journal-title":"Jpn. J. Surg."},{"key":"55603_CR28","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/gut.26.11.1226","volume":"26","author":"TT McCormack","year":"1985","unstructured":"McCormack, T. T. et al. Gastric lesions in portal hypertension: Inflammatory gastritis or congestive gastropathy? Gut. 26, 1226\u20131232 (1985).","journal-title":"Gut."},{"key":"55603_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1746.1991.tb01469.x","volume":"6","author":"GN Tytgat","year":"1991","unstructured":"Tytgat, G. N. The Sydney System: endoscopic division. Endoscopic appearances in gastritis\/duodenitis. J. Gastroenterol. Hepatol. 6, 223\u2013234 (1991).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"55603_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/gast.2001.22580","volume":"120","author":"G Garcia-Tsao","year":"2001","unstructured":"Garcia-Tsao, G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 120, 726\u2013748 (2001).","journal-title":"Gastroenterology."},{"key":"55603_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2036.2010.04331.x","volume":"32","author":"G Vanbiervliet","year":"2010","unstructured":"Vanbiervliet, G. et al. Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment. Pharmacol. Ther. 32, 225\u2013232 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"55603_CR32","doi-asserted-by":"crossref","unstructured":"Rubin, D. B. Multiple imputation for nonresponse in surveys. 258 (John Wiley & Sons, 1987).","DOI":"10.1002\/9780470316696"},{"key":"55603_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes, M. L., Fixen, D. R. & Linnebur, S. A. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther. Adv. Drug. Saf. 8, 273\u2013297 (2017).","journal-title":"Ther. Adv. Drug. Saf."},{"key":"55603_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1590\/S0004-28032007000200012","volume":"44","author":"RB Schechter","year":"2007","unstructured":"Schechter, R. B., Lemme, E. M. O. & Coelho, H. S. M. Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment. Arq. Gastroenterol. 44, 145\u2013150 (2007).","journal-title":"Arq. Gastroenterol."},{"key":"55603_CR35","first-page":"1","volume":"94","author":"SS Chang","year":"2015","unstructured":"Chang, S. S. et al. Risk of spontaneous bacterial peritonitis associated with gastric acid suppression. Medicine (Baltimore). 94, 1\u20137 (2015).","journal-title":"Medicine (Baltimore)."},{"key":"55603_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jhep.2018.04.002","volume":"69","author":"H Otete","year":"2018","unstructured":"Otete, H. et al. Hip fracture risk in patients with alcoholic cirrhosis: a population-based study using English and Danish data. J. Hepatol. 69, 697\u2013704 (2018).","journal-title":"J. Hepatol."},{"key":"55603_CR37","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1053\/jlts.2003.50242","volume":"9","author":"EJ Carey","year":"2003","unstructured":"Carey, E. J., Balan, V., Kremers, W. K. & Hay, J. E. Osteopenia and osteoporosis in patients with end- stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transplant. 9, 1166\u20131173 (2003).","journal-title":"Liver Transplant."},{"key":"55603_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/00952990.2014.964358","volume":"41","author":"PK Mankal","year":"2015","unstructured":"Mankal, P. K. et al. Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population. Am. J. Drug Alcohol Abus. 41, 177\u2013182 (2015).","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"55603_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1272\/jnms.80.252","volume":"80","author":"H Yoshida","year":"2013","unstructured":"Yoshida, H. et al. Risk factors for bleeding esophagogastric varices. J. Nippon Med. Sch. 80, 252\u2013259 (2013).","journal-title":"J. Nippon Med. Sch."},{"key":"55603_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1440-1746.1996.tb00011.x","volume":"11","author":"LS Chen","year":"1996","unstructured":"Chen, L. S. et al. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J. Gastroenterol. Hepatol. 11, 59\u201364 (1996).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"55603_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2165\/00002018-200730090-00003","volume":"30","author":"W Strampel","year":"2007","unstructured":"Strampel, W., Emkey, R. & Civitelli, R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf. 30, 755\u2013763 (2007).","journal-title":"Drug Saf."},{"key":"55603_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jocn.13083","volume":"25","author":"S Polis","year":"2015","unstructured":"Polis, S. et al. Factors associated with medication adherence in patients living with cirrhosis. J. Clin. Nurs. 25, 204\u2013212 (2015).","journal-title":"J. Clin. Nurs."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55603-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:27:57Z","timestamp":1671280077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55603"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55603-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18958"}}